hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI Insight - Mitochondrial metabolic
JCI Insight Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis Persister cancer cells: Iron addiction and vulnerability to ferroptosis: Molecular Cell JCI CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione GPX4 Targeted therapy for drug tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours British Journal of Cancer Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




